Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insulet Corp (NASDAQ:PODD)

33.32
Delayed Data
As of Dec 02
 +0.55 / +1.68%
Today’s Change
23.94
Today|||52-Week Range
45.60
-11.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$1.9B

Company Description

Insulet Corp. is an innovative medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It's current product offering consists of diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Billerica, MA.

Contact Information

Insulet Corp.
600 Technology Park Drive
Billerica Massachusetts 01821
P:(978) 600-7000
Investor Relations:
(978) 600-7717

Employees

Shareholders

Mutual fund holders69.17%
Other institutional40.98%
Individual stakeholders26.69%

Top Executives

Patrick J. SullivanChairman & Chief Executive Officer
Shacey PetrovicPresident & Chief Operating Officer
Michael L. LevitzCFO & Principal Accounting Officer
Michael P. SpearsSVP-Quality, Regulatory & Clinical Affairs
Aiman Abdel-MalekSenior VP-Advanced Technology & Engineering